SmartEnzymes™ for AAV Gene Therapy Applications - Genovis

Select Country

Search

Enzymatic Strategies for Eliminating Neutralizing Antibodies Prior to Administration of AAV Based Gene Therapies | ASGCT (2022)

Please fill out the form to access and download the file

Don't hesitate to contact us if you experience any problems with this feature.

First Name Last Name Email Phone Country Company I agree to get the latest news and offers

By providing us with your contact details, you accept our Data Protection Policy.

Required field

Related Applications

Eliminating Neutralizing Antibodies Prior to AAV-based Gene Therapies using Xork™
Application
Efficient IgG cleavage with a low immunogenicity risk enzyme, supporting clearance of neutralizing antibodies to improve gene therapy administration.